Nasus Pharma Ltd - NSRX

Sector: Healthcare · Industry: Pharmaceutical Preparations
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q2 2026 · Q1 2026
Value (USD)
Total reported value ($000)
$7.522M
QoQ value delta ($000)
+$2.7M (+55.99%)
Implied price effect (QoQ)
+57.72%
Shares
Total shares
2,150,411
QoQ shares delta
-23,863 (-1.1%)
Total shares held by funds (by quarter)
Shares (left)

Fund holders include prior positions carried forward until a new 13F confirms a change. Reported holders have reported a position in this security for that quarter; this is not the total number of 13F filers.

Market chart (NSRX)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q2 2026)

Top 25 only Full list
Manager Value ($000) Shares % of 13F
BALYASNY ASSET MANAGEMENT L.P. 3,144 898,473 0.0%
Cable Car Capital, LP 2,156 616,081 0.05%
Velan Capital Investment Management LP 1,257 359,390 0.77%
Hudson Bay Capital Management LP 471 134,771 0.0%
Bleichroeder LP 314 89,848 0.06%
CITADEL ADVISORS LLC 77 22,004 0.0%
XTX Topco Ltd 58 16,640 0.0%
RENAISSANCE TECHNOLOGIES LLC 42 12,200 0.0%
MORGAN STANLEY 3 1,000 0.0%
Caitong International Asset Management Co., Ltd 0 4 0.0%